|
|||||
|
|
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia |
|
| Authors: | Preetesh Jain MD PhD Hun Ju Lee MD Wei Qiao William Wierda MD PhD Ohad Benjamini MD Jan Burger MD PhD Alessandra Ferrajoli MD Zeev Estrov MD Hagop Kantarjian MD Michael Keating MD Susan O'Brien MD |
| Affiliation: | 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | chronic lymphocytic leukemia, CLL bevacizumab anti-angiogenic therapy chemoimmunotherapy FCR |